These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2971497)

  • 21. [Crossed cerebellar diaschisis in cerebrovascular disease detected by N-isopropyl I-123 p-iodoamphetamine (I-123 IMP) with SPECT].
    Momose T; Kosaka N; Nishikawa J; Machida K; Ohtake T; Tsuchiya K; Machida T; Watanabe E; Iio M
    Kaku Igaku; 1986 Jan; 23(1):25-34. PubMed ID: 3486304
    [No Abstract]   [Full Text] [Related]  

  • 22. [Value of regional cerebral perfusion SPECT with N-isopropyl-(I-123)p-iodoamphetamine (IMP) in brain tumors].
    Nishizawa S; Tanada S; Fujita T; Yonekura Y; Senda M; Ishikawa M; Torizuka K
    Kaku Igaku; 1987 Jan; 24(1):15-25. PubMed ID: 3494867
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical assessment of cerebral blood flow image using N-isopropyl-p-[123I]iodoamphetamine (IMP) and single photon emission computed tomography (SPECT)].
    Shiozaki H; Kishikawa T; Ikeda J; Baba H; Fujii K; Shibasaki H
    Kaku Igaku; 1985 Apr; 22(4):449-58. PubMed ID: 3874308
    [No Abstract]   [Full Text] [Related]  

  • 24. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease.
    Harris GJ; Aylward EH; Peyser CE; Pearlson GD; Brandt J; Roberts-Twillie JV; Barta PE; Folstein SE
    Arch Neurol; 1996 Apr; 53(4):316-24. PubMed ID: 8929153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional dynamics of N-isopropyl-(123I)p-iodoamphetamine in human brain.
    Nishizawa S; Tanada S; Yonekura Y; Fujita T; Mukai T; Saji H; Fukuyama H; Miyoshi T; Harada K; Ishikawa M
    J Nucl Med; 1989 Feb; 30(2):150-6. PubMed ID: 2786930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.
    Furukawa F; Ishikawa K; Yokota T; Sanjo N
    Eur Neurol; 2019; 81(1-2):13-18. PubMed ID: 31013498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: concise communication.
    Hill TC; Holman BL; Lovett R; O'Leary DH; Front D; Magistretti P; Zimmerman RE; Moore S; Clouse ME; Wu JL; Lin TH; Baldwin RM
    J Nucl Med; 1982 Mar; 23(3):191-5. PubMed ID: 6977624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I-123 Iofetamine SPECT scan in children with neurological disorders.
    Flamini JR; Konkol RJ; Wells RG; Sty JR
    Wis Med J; 1990 Oct; 89(10):584-7. PubMed ID: 2238681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical cerebral blood flow thresholds studied by SPECT using xenon-133 and iodine-123 iodoamphetamine.
    Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
    J Nucl Med; 1989 Mar; 30(3):337-42. PubMed ID: 2786938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease.
    Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE
    Psychiatry Res; 1989 Sep; 29(3):361-2. PubMed ID: 2532753
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of single-photon emission computed tomography with [123I]iodoamphetamine and xenon-enhanced computed tomography for assessing regional cerebral blood flow.
    Hellman RS; Collier BD; Tikofsky RS; Kilgore DP; Daniels DL; Haughton VM; Walsh PR; Cusick JF; Saxena VK; Palmer DW
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):747-55. PubMed ID: 3025234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging.
    Hellman RS; Tikofsky RS; Collier BD; Hoffmann RG; Palmer DW; Glatt SL; Antuono PG; Isitman AT; Papke RA
    Radiology; 1989 Jul; 172(1):183-8. PubMed ID: 2787034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders.
    O'Connell RA; Van Heertum RL; Billick SB; Holt AR; Gonzalez A; Notardonato H; Luck D; King LN
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):145-53. PubMed ID: 2521055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of regional cerebral blood flow in hippocampus by 99mTc-ECD SPECT: comparison with 123I-IMP SPECT].
    Matsumura K; Watanabe Y; Aoki S; Nakashima H; Maeda H; Hirano T; Takeda K; Nakagawa T
    Kaku Igaku; 1996 Sep; 33(9):1021-6. PubMed ID: 8921672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease?
    Lang C
    Neuroradiology; 1985; 27(2):161-3. PubMed ID: 3157882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal evolution of brain distribution of IMP and HIPDM. Concise communication.
    Moretti JL; Kung HF; Cesaro P; Blau M; Defer G; Holman L; Vigneron N; Rapin JR
    Nucl Med Commun; 1987 Jul; 8(7):597-602. PubMed ID: 3500438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single photon emission computed tomography in subjects at risk for Huntington's chorea.
    Leblhuber F; Brucker B; Reisecker F; Steinparz F; Windhager E; Trenkler J; Deisenhammer E
    J Neurol; 1990 Dec; 237(8):496-8. PubMed ID: 2150077
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuropathologic correlation of computerized tomography in Huntington's disease.
    Terrence CF; Rao G
    South Med J; 1980 Jun; 73(6):817-8. PubMed ID: 6446759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional quantitative noninvasive assessment of cerebral perfusion and function with N-isopropyl-[123I]p-iodoamphetamine.
    von Schulthess GK; Ketz E; Schubiger PA; Bekier A
    J Nucl Med; 1985 Jan; 26(1):9-16. PubMed ID: 3965658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.